ATE251460T1 - Verwendung von danazol zur behandlung von hypogonadismus in männern - Google Patents

Verwendung von danazol zur behandlung von hypogonadismus in männern

Info

Publication number
ATE251460T1
ATE251460T1 AT99913484T AT99913484T ATE251460T1 AT E251460 T1 ATE251460 T1 AT E251460T1 AT 99913484 T AT99913484 T AT 99913484T AT 99913484 T AT99913484 T AT 99913484T AT E251460 T1 ATE251460 T1 AT E251460T1
Authority
AT
Austria
Prior art keywords
ethisterone
danazole
men
male
hypogonadism
Prior art date
Application number
AT99913484T
Other languages
English (en)
Inventor
Malcolm E Carruthers
Original Assignee
Multimed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multimed Ltd filed Critical Multimed Ltd
Application granted granted Critical
Publication of ATE251460T1 publication Critical patent/ATE251460T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AT99913484T 1998-04-09 1999-03-29 Verwendung von danazol zur behandlung von hypogonadismus in männern ATE251460T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9807809.0A GB9807809D0 (en) 1998-04-09 1998-04-09 Compositions comprising ethisterone or its derivatives
PCT/GB1999/000984 WO1999052533A1 (en) 1998-04-09 1999-03-29 Compositions comprising ethisterone or its derivatives

Publications (1)

Publication Number Publication Date
ATE251460T1 true ATE251460T1 (de) 2003-10-15

Family

ID=10830241

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99913484T ATE251460T1 (de) 1998-04-09 1999-03-29 Verwendung von danazol zur behandlung von hypogonadismus in männern

Country Status (8)

Country Link
EP (1) EP1079836B1 (de)
AT (1) ATE251460T1 (de)
AU (1) AU759767B2 (de)
DE (1) DE69911955T2 (de)
DK (1) DK1079836T3 (de)
ES (1) ES2212844T3 (de)
GB (1) GB9807809D0 (de)
WO (1) WO1999052533A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1919290T3 (da) 2005-07-12 2014-04-22 Ampio Pharmaceuticals Inc Fremgangsmåder og produkter til behandling af sygdomme
HRP20130123T1 (hr) 2009-06-22 2013-03-31 Dmi Acquisition Corp. Postupak lijeäśenja bolesti
CN104968350A (zh) 2012-12-19 2015-10-07 安皮奥制药股份有限公司 疾病的治疗方法
CN107375910B (zh) * 2017-07-12 2020-03-24 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 PTHrP在制备治疗男性性腺功能低下综合征中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595970A (en) * 1993-07-16 1997-01-21 Schering Aktiengesellschaft Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors
AU1429697A (en) * 1995-12-29 1997-07-28 Cygnus, Inc. Systems and methods for the transdermal administration of androgenic agents
DE19619045C1 (de) * 1996-05-02 1997-11-13 Jenapharm Gmbh Verwendung von Kombinationspräparaten zur Behandlung hypogonadaler Männer sowie Männern mit Hypophysenerkrankungen

Also Published As

Publication number Publication date
GB9807809D0 (en) 1998-06-10
AU3159899A (en) 1999-11-01
DK1079836T3 (da) 2004-02-16
EP1079836A1 (de) 2001-03-07
ES2212844T3 (es) 2004-08-01
EP1079836B1 (de) 2003-10-08
AU759767B2 (en) 2003-05-01
DE69911955T2 (de) 2004-08-12
WO1999052533A1 (en) 1999-10-21
DE69911955D1 (de) 2003-11-13

Similar Documents

Publication Publication Date Title
EA200300313A1 (ru) Фармацевтическая композиция и способ лечения гипогонадизма
CY1108563T1 (el) Μεθοδοι και υλικα για τη θεραπεια της ανεπαρκειας (ελλειψης) τεστοστερονης στους ανδρες
ATE279916T1 (de) Verwendung von substanzen, die die östrogen wirkung fördern, zur behandlung von wunden
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE313326T1 (de) VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß
ATE250576T1 (de) Substituierte pyrrolylverbindungen zur behandlung von entzündungen
ATE242632T1 (de) Verwendung von betulinsäure-derivaten zur behandlung und vorbeugung von melanomen
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
DE60036169D1 (de) Methoden zur Behandlung der Hautpigmentierung
PT991619E (pt) Inibidores da adesao celular mediada pela alfa4beta1
ATE245416T1 (de) Neue fettanaloge zur behandlung von diabetes
MXPA03005742A (es) Combinacion de un estrogeno y un androgeno para tratar deficiencias hormonales en mujeres que sufren terapia de reemplazo de estrogenos.
ATE300295T1 (de) Verwendung von baclofen zur behandlung von alkoholismus
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
DE69829202D1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
ATE251460T1 (de) Verwendung von danazol zur behandlung von hypogonadismus in männern
ATE253368T1 (de) Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE59900286D1 (de) Verwendung von sphingosin-1-phosphat, sphingosin-1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
ES2180345T3 (es) Nuevo procedimiento para la crio-conservacion de plantas.
ATE208202T1 (de) Verwendung von dimeticon zur behandlung der konstipation
ATE470452T1 (de) Impfstoff enthaltend lactobacilli zur behandlung von entzündungen der prostata und gutartigen prostata-hyperplasien
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties